326 related articles for article (PubMed ID: 18571782)
1. A novel human disease with abnormal prion protein sensitive to protease.
Gambetti P; Dong Z; Yuan J; Xiao X; Zheng M; Alshekhlee A; Castellani R; Cohen M; Barria MA; Gonzalez-Romero D; Belay ED; Schonberger LB; Marder K; Harris C; Burke JR; Montine T; Wisniewski T; Dickson DW; Soto C; Hulette CM; Mastrianni JA; Kong Q; Zou WQ
Ann Neurol; 2008 Jun; 63(6):697-708. PubMed ID: 18571782
[TBL] [Abstract][Full Text] [Related]
2. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.
Zou WQ; Puoti G; Xiao X; Yuan J; Qing L; Cali I; Shimoji M; Langeveld JP; Castellani R; Notari S; Crain B; Schmidt RE; Geschwind M; Dearmond SJ; Cairns NJ; Dickson D; Honig L; Torres JM; Mastrianni J; Capellari S; Giaccone G; Belay ED; Schonberger LB; Cohen M; Perry G; Kong Q; Parchi P; Tagliavini F; Gambetti P
Ann Neurol; 2010 Aug; 68(2):162-72. PubMed ID: 20695009
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
4. Variably protease-sensitive prionopathy mimicking frontotemporal dementia.
Aizpurua M; Selvackadunco S; Yull H; Kipps CM; Ironside JW; Bodi I
Neuropathology; 2019 Apr; 39(2):135-140. PubMed ID: 30847986
[TBL] [Abstract][Full Text] [Related]
5. Variably protease-sensitive prionopathy: a novel disease of the prion protein.
Gambetti P; Puoti G; Zou WQ
J Mol Neurosci; 2011 Nov; 45(3):422-4. PubMed ID: 21584652
[TBL] [Abstract][Full Text] [Related]
6. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
[TBL] [Abstract][Full Text] [Related]
7. Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.
Head MW; Yull HM; Ritchie DL; Langeveld JP; Fletcher NA; Knight RS; Ironside JW
Brain; 2013 Apr; 136(Pt 4):1102-15. PubMed ID: 23550113
[TBL] [Abstract][Full Text] [Related]
8. Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells.
Grenier C; Bissonnette C; Volkov L; Roucou X
J Neurochem; 2006 Jun; 97(5):1456-66. PubMed ID: 16696854
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
10. Variable Protease-Sensitive Prionopathy Transmission to Bank Voles.
Nonno R; Notari S; Di Bari MA; Cali I; Pirisinu L; d'Agostino C; Cracco L; Kofskey D; Vanni I; Lavrich J; Parchi P; Agrimi U; Gambetti P
Emerg Infect Dis; 2019 Jan; 25(1):73-81. PubMed ID: 30561322
[TBL] [Abstract][Full Text] [Related]
11. PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia.
Hall DA; Leehey MA; Filley CM; Steinbart E; Montine T; Schellenberg GD; Bosque P; Nixon R; Bird T
Neurology; 2005 Apr; 64(7):1304-6. PubMed ID: 15824374
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease.
Rodriguez MM; Peoc'h K; Haïk S; Bouchet C; Vernengo L; Mañana G; Salamano R; Carrasco L; Lenne M; Beaudry P; Launay JM; Laplanche JL
Neurology; 2005 Apr; 64(8):1455-7. PubMed ID: 15851745
[TBL] [Abstract][Full Text] [Related]
13. A new prionopathy.
Will R; Head M
Ann Neurol; 2008 Jun; 63(6):677-8. PubMed ID: 18570344
[No Abstract] [Full Text] [Related]
14. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
15. Variably protease-sensitive prionopathy.
Notari S; Appleby BS; Gambetti P
Handb Clin Neurol; 2018; 153():175-190. PubMed ID: 29887135
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes.
Kovács GG; Head MW; Hegyi I; Bunn TJ; Flicker H; Hainfellner JA; McCardle L; László L; Jarius C; Ironside JW; Budka H
Brain Pathol; 2002 Jan; 12(1):1-11. PubMed ID: 11770893
[TBL] [Abstract][Full Text] [Related]
17. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
18. Absence of protease-resistant prion protein in dementia characterized by neuronal loss and status spongiosus.
Pollanen MS; Bergeron C; Weyer L
Acta Neuropathol; 1993; 86(5):515-7. PubMed ID: 8310801
[TBL] [Abstract][Full Text] [Related]
19. Protease-sensitive synthetic prions.
Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
[TBL] [Abstract][Full Text] [Related]
20. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity.
Gelpi E; Kovacs GG; Ströbel T; Koperek O; Voigtländer T; Liberski PP; Budka H
Acta Neuropathol; 2005 Nov; 110(5):513-9. PubMed ID: 16155763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
